UBS AM’s bluebird bio BLUE Stock Holding History

UBS AM’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,767	Closed	-$411K	–	2553
2023 Q3	$411K	Buy	6,767 +5,672	+518%	+$398K	﹤0.01%	2358
2023 Q2	$69.7K	Hold	1,095	–	–	﹤0.01%	2656
2023 Q1	$69.7K	Buy	1,095 +10	+0.9%	+$1.14K	﹤0.01%	2656
2022 Q4	$150K	Buy	+1,085	New	+$153K	﹤0.01%	2475
2022 Q2	–	Sell	-3,269	Closed	-$317K	–	2699
2022 Q1	$317K	Hold	3,269	–	–	﹤0.01%	2582
2021 Q4	$653K	Sell	3,269 -2,112	-39%	-$498K	﹤0.01%	2436
2021 Q3	$1.33M	Buy	5,381 +255	+5%	+$72.9K	﹤0.01%	2023
2021 Q2	$2.12M	Sell	5,126 -1,893	-27%	-$750K	﹤0.01%	1819
2021 Q1	$2.74M	Sell	7,019 -30,527	-81%	-$15M	﹤0.01%	1625
2020 Q4	$21M	Buy	37,546 +11,667	+45%	+$7.39M	0.01%	834
2020 Q3	$18.1M	Buy	25,879 +67	+0.3%	+$52.3K	0.01%	796
2020 Q2	$20.4M	Buy	25,812 +2,999	+13%	+$2.26M	0.01%	732
2020 Q1	$13.6M	Sell	22,813 -4,817	-17%	-$4.69M	0.01%	787
2019 Q4	$31.4M	Sell	27,630 -4,035	-13%	-$4.39M	0.02%	656
2019 Q3	$37.7M	Buy	31,665 +4,037	+15%	+$6.16M	0.03%	600
2019 Q2	$45.5M	Sell	27,628 -6,513	-19%	-$11.3M	0.03%	557
2019 Q1	$69.6M	Sell	34,141 -1,962	-5%	-$3.45M	0.05%	378
2018 Q4	$46.4M	Buy	36,103 +4,248	+13%	+$6.52M	0.04%	469
2018 Q3	$60.2M	Buy	31,855 +26,252	+469%	+$54.2M	0.04%	431
2018 Q2	$11.4M	Buy	5,603 +728	+15%	+$1.66M	0.01%	915
2018 Q1	$10.8M	Sell	4,875 -446	-8%	-$1.13M	0.01%	914
2017 Q4	$12.3M	Sell	5,321 -12,084	-69%	-$24.5M	0.01%	865
2017 Q3	$31M	Sell	17,405 -842	-5%	-$1.18M	0.03%	595
2017 Q2	$24.8M	Buy	18,247 +4,564	+33%	+$5.51M	0.02%	668
2017 Q1	$16.1M	Sell	13,683 -4,173	-23%	-$4.26M	0.02%	776
2016 Q4	$14.3M	Sell	17,856 -780	-4%	-$619K	0.02%	785
2016 Q3	$16.4M	Buy	18,636 +7,365	+65%	+$5.33M	0.02%	751
2016 Q2	$6.32M	Sell	11,271 -901	-7%	-$510K	0.01%	967
2016 Q1	$6.7M	Buy	12,172 +92	+0.8%	+$56.5K	0.01%	953
2015 Q4	$10M	Sell	12,080 -1,160	-9%	-$1.16M	0.01%	867
2015 Q3	$14.7M	Sell	13,240 -6,912	-34%	-$12.6M	0.02%	768
2015 Q2	$44M	Sell	20,152 -22,138	-52%	-$45.1M	0.04%	455
2015 Q1	$66.2M	Buy	42,290 +1,677	+4%	+$2.21M	0.06%	328
2014 Q4	$48.3M	Buy	40,613 +11,135	+38%	+$7.44M	0.05%	428
2014 Q3	$13.7M	Buy	29,478 +371	+1%	+$171K	0.01%	767
2014 Q2	$14.5M	Buy	29,107 +6,584	+29%	+$2.11M	0.01%	756
2014 Q1	$6.63M	Buy	22,523 +3,934	+21%	+$1.19M	0.01%	968
2013 Q4	$5.05M	Sell	18,589 -354	-2%	-$98.9K	0.01%	1006
2013 Q3	$6.62M	Buy	+18,943	New	+$7.04M	0.01%	909

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

GCM

Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return

UBS AM's BLUE Position: Q4 2023 in Review

UBS AM sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 6,767 shares — an estimated $411K sold.

UBS AM first reported a position in BLUE in Q3 2013 and held it in 39 quarters. The position peaked at $69.6M in Q1 2019. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.

UBS AM reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
UBS AM sold 6,767 bluebird bio shares in Q4 2023, an estimated $411K.
UBS AM first reported a position in bluebird bio in Q3 2013 and held it in 39 quarters.
UBS AM's bluebird bio position peaked at $69.6M in Q1 2019.
187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.

Based on UBS AM's 13F filing for Q4 2023, filed 14 Feb 2024.